Preventing the development of severe COVID-19 by modifying immunothrombosis
Version 2 2024-06-05, 04:22
Version 1 2020-11-04, 12:19
journal contribution
posted on 2024-06-05, 04:22 authored by G Morris, CC Bortolasci, BK Puri, Lisa OliveLisa Olive, Wolf MarxWolf Marx, Adrienne O'NeilAdrienne O'Neil, Eugene AthanEugene Athan, A Carvalho, M Maes, Ken WalderKen Walder, Michael BerkMichael BerkPreventing the development of severe COVID-19 by modifying immunothrombosis
History
Journal
Life SciencesVolume
264Article number
ARTN 118617Pagination
1 - 15Location
NetherlandsPublisher DOI
Open access
- Yes
Link to full text
ISSN
0024-3205eISSN
1879-0631Language
EnglishPublication classification
C1 Refereed article in a scholarly journalPublisher
PERGAMON-ELSEVIER SCIENCE LTDUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalPharmacology & PharmacyResearch & Experimental MedicineCOVID-19SARS-CoV-2Respiratory infectionTreatmentNF-KAPPA-BACETYL-L-CYSTEINEOBSTRUCTIVE PULMONARY-DISEASERESPIRATORY-DISTRESS-SYNDROMEACUTE LUNG INJURYASPIRIN-TRIGGERED LIPOXINSVITAMIN-C PHARMACOKINETICSBRONCHIAL EPITHELIAL-CELLSOXIDATIVE STRESS MARKERSZINC TRANSPORTER ZIP14110999 Neurosciences not elsewhere classified920410 Mental HealthInstitute for Innovation in Mental and Physical Health and Clinical TranslationSchool of MedicineFaculty of Health3209 Neurosciences3204 Immunology3208 Medical physiology420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC